In vitro variables of apheresis platelets are stably maintained for 7 days with 5% residual plasma in a glucose and bicarbonate salt solution, PAS-5

Transfusion

Volumn 52, Issue 1, 2012, Pages 188-194

  Radwanski, Katherine ^a,b   Wagner, Stephen J ^a,b   Skripchenko, Andrey ^a,b   Min, Kyungyoon ^a,b  

^a Fenwal Inc   (United States)

^b HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; GLUCOSE; LACTATE DEHYDROGENASE; OXYGEN; PLATELET ADDITIVE SOLUTION 3; PLATELET ADDITIVE SOLUTION 5; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ARTICLE; BICARBONATE BLOOD LEVEL; CARBON DIOXIDE TENSION; CELL STRUCTURE; CENTRIFUGATION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPOTONIC SHOCK RESPONSE; IN VITRO STUDY; LABORATORY DEVICE; OXYGEN TENSION; PH; REGULATORY MECHANISM; SCORING SYSTEM; SEPARATOR; THROMBOCYTE VOLUME; THROMBOCYTOPHERESIS;

BICARBONATES; BLOOD PRESERVATION; GLUCOSE; HUMANS; PLASMA; PLATELETPHERESIS; SOLUTIONS;

EID: 84855356443     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03252.x     Document Type: Article

References (31)

1. Holme S, Heaton WA, Courtright M,. Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution. Br J Haematol 1987; 66: 233-8. (Pubitemid 17087422)
2. Rock G, White J, Labow R,. Storage of platelets in balanced salt solutions: a simple platelet storage medium. Transfusion 1991; 31: 21-5.
3. van der Meer PF, Pietersz RN, Reesink HW,. Comparison of two platelet additive solutions. Trans Med 2001; 11: 193-7. (Pubitemid 32606735)
4. van Rhenen DJ, Vermeu H, Kappers-Klunne M, Payrat JM,. Evaluation of a new citrate-acetate NaCl platelet additive solution for the storage of white cell-reduced platelet concentrates obtained from half-strength CPD pooled buffy coats. Transfusion 1995; 35: 50-3.
5. Hornsey VS, McColl K, Drummond O, McMillan L, Morrison A, Morrison L, MacGregor IR, Prowse CV,. Extended storage of platelets in SSP platelet additive solution. Vox Sang 2006; 91: 41-6. (Pubitemid 43822303)
6. Gulliksson H, Larsson S, Kumlien G, Shanwell A,. Storage of platelets in additive solutions: effects of phosphate. Vox Sang 2000; 78: 176-84. (Pubitemid 30248957)
7. Vassallo RR, Adamson JW, Gottschall JL, Snyder EL, Lee W, Houghton J, Elfath MD,. In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma. Transfusion 2010; 50: 2376-85.
8. Strong DM, Shoos Lipton K,. Transfusion-related acute lung injury. AABB Association Bulletin 06-07. Bethesda (MD): American Association of Blood Banks; 2006.
9. Heddle NM, Blajchman MA, Meyer RM, Lipton JH, Walker IR, Sher GD, Constantini LA, Patterson B, Roberts RS, Thorpe KE, Levine MN,. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 2002; 42: 556-66.
10. Vo TD, Cowles J, Heal JM, Blumberg N,. Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusion. Trans Med 2001; 11: 45-7. (Pubitemid 32180321)
11. Holme S,. Effect of additive solutions on platelet biochemistry. Blood Cells 1992; 18: 421-30.
12. Skripchenko A, Myrup A, Thompson-Montgomery D, Awatefe H, Moroff G, Wagner SJ,. Effect of plasma levels on the in vitro properties of platelets suspended in additive solution. Transfusion 2008; 48S: 142A. [abstract SP311].
13. Hirayama J, Azuma H, Fujihara M, Homma C, Yamamoto S, Ikeda H,. Storage of platelets in a novel additive solution (M-sol), which is prepared by mixing solutions approved for clinical use that are not especially for platelet storage. Transfusion 2007; 47: 960-5. (Pubitemid 46802082)
14. Wagner SJ, Skripchenko A, Myrup A, Thompson-Montgomery D, Awatefe H, Moroff G,. Calcium is a key constituent for maintaining the in vitro properties of platelets suspended in the bicarbonate-containing additive solution M-sol with low plasma levels. Transfusion 2010; 50: 1028-35.
15. Azuma H, Hirayama J, Akino M, Miura R, Kiyama Y, Imai K, Kasai M, Koizumi K, Kakinoki Y, Makiguchi Y, Kobo K, Atsuta Y, Fujihara M, Homma C, Yamamoto S, Kato T, Ikeda H,. Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol). Transfusion 2009; 49: 214-8.
16. Radwanski K, Min K, Mayaudon V, Payrat JM,. In vitro comparison of apheresis platelet concentrates stored with 15% or 20% plasma in reformulated PAS. Transfusion 2009; 49S: 89A. [abstract SP97].
17. Radwanski K, Min K,. Storage of apheresis platelets with low residual plasma in reformulated PAS with bicarbonate. Vox Sang 2010; 99 (Suppl 1): 220. [abstract P-0347].
18. Kunicki TJ, Tuccelli M, Becker GA, Aster RH,. A study of variables affecting the quality of platelets stored at "room temperature." Transfusion 1975; 15: 414-21.
19. Holme S, Moroff G, Murphy S,. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Transfusion 1998; 38: 31-40. (Pubitemid 28090937)
20. Curvers J, de Wildt-Eggen J, Heeremans J, Scharenberg J, de Korte D, van der Meer PF,. Flow cytometric measurement of CD62P (P-selectin) expression on platelets: a multicenter optimization and standardization effort. Transfusion 2008; 48: 1439-46.
21. Gulliksson H, Aubuchon JP, Cardigan R, van der Meer PF, Murphy S, Prowse C, Richter E, Ringwald J, Smacchia C, Slichter S, de Wildt-Eggen J,. Storage of platelets in additive solutions: a multicenter study of the in vitro effects of potassium and magnesium. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Vox Sang 2003; 85: 199-205.
22. Diedrich B, Sandgren P, Jansson B, Gullikson H, Svensson L, Shanwell A,. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution. Vox Sang 2008; 94: 96-102.
23. Holme S, Heaton WA, Courtright M,. Platelet storage lesion in second-generation containers: correlation with platelet ATP levels. Vox Sang 1987; 53: 214-20. (Pubitemid 18006498)
24. Bertolini F, Murphy S, Rebulla P, Sirchia G,. Role of acetate during platelet storage in a synthetic medium. Transfusion 1992; 32: 152-6.
25. Gullikson H,. Storage of platelets in additive solutions: theeffect of citrate and acetate in in vitro studies. Transfusion 1993; 33: 301-3.
26. Serious Hazards of Transfusion Steering Committee. Serious hazards of transfusion: annual report 2009 [monograph on the Internet]. Manchester (UK): SHOT Office; 2010. Available from
27. Rebulla P, Bertolini F, Riccardi D, Smacchia C, Sirchia G,. Platelet concentrates prepared from pooled buffy-coats and stored in a glucose-free crystalloid medium. The Milan experience. Transfus Sci 1990; 11: 357-62.
28. Steigler G, Leitner G, Jurko S, Gerhartl K, Panzer S, Höcker P,. Five-day storage of apheresis platelet concentrates in the new additive solution T-Sol™: changes of metabolic markers. Infus Ther Transfus Med 2002; 29: 18-22. (Pubitemid 34195745)
29. Tobian A, Savage W, Tisch D, Thoman A, King K, Ness P,. Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion 2011; 51: 1676-83.
30. De Wildt-Eggen J, Nauta S, Schrijver JG, Van Marwijk Kooy M, Bins M, Van Prooijen HC,. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study. Transfusion 2000; 40: 398-403. (Pubitemid 30230501)
31. Snyder E, McCullough J, Slichter SJ, Strauss RG, Lopez-Plaza I, Lin JS, Corash L, Conlan MG,; SPRINT Study Group. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Transfusion 2005; 45: 1864-75. (Pubitemid 43971413)